Literature DB >> 25536671

Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practice.

Edouard Louis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25536671     DOI： 10.1093/ecco-jcc/jju012

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  8 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 2.  Clinical Utility of Biomarkers in IBD.

Authors:  Gerhard Rogler; Luc Biedermann
Journal:  Curr Gastroenterol Rep       Date:  2015-07

3.  Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients.

Authors:  Kathryn Clarkston; Yi-Ting Tsai; Kimberly Jackson; Michael J Rosen; Lee A Denson; Phillip Minar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-07       Impact factor: 2.839

4.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

5.  Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.

Authors:  Lei Ye; Yu-Ping Zhang; Na Yu; Ya-Xu Jia; Shu-Jun Wan; Fang-Yu Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.

Authors:  Eva Klingberg; Maria K Magnusson; Hans Strid; Anna Deminger; Arne Ståhl; Johanna Sundin; Magnus Simrén; Hans Carlsten; Lena Öhman; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2019-11-27       Impact factor: 5.156

7.  Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn's Disease and Ulcerative Colitis.

Authors:  Viktor Domislovic; Joachim Høg Mortensen; Majken Lindholm; Morten Asser Kaarsdal; Marko Brinar; Ana Barisic; Tina Manon-Jensen; Zeljko Krznaric
Journal:  J Clin Med       Date:  2022-10-07       Impact factor: 4.964

8.  Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab.

Authors:  Phillip Minar; Christina Lehn; Yi-Ting Tsai; Kimberly Jackson; Michael J Rosen; Lee A Denson
Journal:  Crohns Colitis 360       Date:  2019-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.